M Schwenn
Overview
Explore the profile of M Schwenn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu J, Cross A, Baris D, Ward M, Karagas M, Johnson A, et al.
Br J Cancer
. 2012 May;
106(11):1891-8.
PMID: 22568968
Background: Despite many studies on diet and bladder cancer, there are areas that remain unexplored including meat mutagens, specific vegetable groups, and vitamins from diet. Methods: We conducted a population-based...
2.
Laver J, Mahmoud H, Pick T, Hutchinson R, Weinstein H, Schwenn M, et al.
Leuk Lymphoma
. 2001 Nov;
42(3):399-405.
PMID: 11699405
The Pediatric Oncology Group (POG) adopted a histology-based approach to the management of pediatric non-Hodgkin's lymphomas (NHL) utilizing the National Cancer Institute Working Formulation for Clinical Usage. Patients with diffuse...
3.
Waber D, Carpentieri S, Klar N, Silverman L, Schwenn M, Hurwitz C, et al.
J Pediatr Hematol Oncol
. 2000 Jun;
22(3):206-13.
PMID: 10864051
Purpose: The cognitive sequelae of treatment for childhood acute lymphoblastic leukemia (ALL) were compared in a group of patients who received dexamethasone during the intensification and maintenance phases of therapy...
4.
Laver J, Barredo J, Amylon M, Schwenn M, Kurtzberg J, Camitta B, et al.
Leukemia
. 2000 Mar;
14(3):369-73.
PMID: 10720128
Contemporary chemotherapy has significantly improved event-free survival among patients with T cell-lineage acute lymphoblastic leukemia (T-ALL). Unlike B-precursor ALL, most investigators are still using cranial radiation (CRT) and are hesitant...
5.
Hutchison R, Finch C, Kepner J, Fuller C, Bowman P, Link M, et al.
Ann Oncol
. 2000 Mar;
11 Suppl 1:35-8.
PMID: 10707776
Introduction: Burkitt-like lymphoma (BLL) is a provisional category of B-cell lymphoma which is morphologically intermediate between Burkitt lymphoma (BL) and large B-cell lymphoma (LBCL). The clinical significance of this morphology...
6.
Laver J, Amylon M, Desai S, Link M, Schwenn M, Mahmoud H, et al.
J Clin Oncol
. 1998 Feb;
16(2):522-6.
PMID: 9469336
Purpose: Contemporary chemotherapy has significantly improved the event-free survival (EFS) among patients with T-cell disease. However, myelosuppression has been a significant adverse effect of this approach. In this study, we...
7.
Hutchison R, Banki K, Shuster J, Barrett D, DIECK C, BERARD C, et al.
Ann Oncol
. 1997 Jan;
8 Suppl 1:37-42.
PMID: 9187427
Background: Anaplastic lymphoma kinase (ALK) is a tyrosine kinase inappropriately expressed in lymphoid tissue involved by CD30+ anaplastic large-cell lymphoma (ALCL) with the translocation t(2;5)(p23;q35)(, which juxtaposes the nucleophosmin gene...
8.
Katz J, Hvizdala E, Shuster J, Falletta J, Schwenn M, MURPHY S
J Clin Oncol
. 1993 Oct;
11(10):2054-5.
PMID: 8410135
No abstract available.
9.
Kung F, Pratt C, Vega R, Jaffe N, Strother D, Schwenn M, et al.
Cancer
. 1993 Mar;
71(5):1898-903.
PMID: 8448755
Background: The prognosis for children with recurrent or resistant malignant solid tumors remains dismal. More effective rescue therapy is needed for these children. Methods: Between August 1987 and November 1990,...
10.
Sonis A, Tarbell N, Valachovic R, Gelber R, Schwenn M, Sallan S
Cancer
. 1990 Dec;
66(12):2645-52.
PMID: 2249205
Ninety-seven children who were diagnosed with acute lymphoblastic leukemia before 10 years of age and treated with chemotherapy alone, chemotherapy plus 1800-cGy cranial irradiation (RT), or chemotherapy plus 2400-cGy RT...